In 2023, insurers denied about one in five in-network health claims, yet fewer than 1% of denied claims were ever appealed, and of the ones that were, roughly 44% got overturned. For testosterone therapy, that gap is where most men lose coverage they were entitled to, they never learned what their plan actually requires, or that a denial is only the opening position in a process they can win.
Whether insurance covers your TRT comes down to documentation, the diagnosis, the lab timing, the codes, and the paperwork that clears your plan’s medical-necessity bar.
This guide breaks down exactly what insurers require, how coverage differs across plan types and companies, why claims get denied, and the step-by-step appeal process, with a fill-in-the-blank medical-necessity letter you can download. By the end, you’ll know where your situation stands and what to do about it.
Does insurance cover TRT? The short answer
Yes, when it’s medically necessary and documented. Most private plans, Medicare, and many Medicaid programs cover testosterone replacement therapy when you have a confirmed diagnosis of hypogonadism (clinically low testosterone), documented symptoms, and lab work that proves it. What they won’t cover is testosterone for age-related decline alone, performance or “optimization,” or general fatigue with no diagnosis behind it.
Coverage comes down to which category your situation falls into. The rest of this guide is about locating yours, and moving it into the covered column wherever that’s possible.
What insurance requires to cover TRT (the 4-point medical necessity checklist)
Nearly every insurer applies the same four-part test. Miss one and the claim stalls.
- Two low morning testosterone readings: Most plans require two separate early-morning blood tests below their threshold, commonly 300 ng/dL, though some set it between 250 and 350, drawn on different days. UnitedHealthcare’s own policy, for example, requires two morning total-testosterone levels under 300 ng/dL (or below the lab’s reference range), or one low free/bioavailable reading.
- Documented symptoms: Low numbers alone aren’t enough. Your record needs the clinical picture, fatigue, low libido, erectile changes, mood shifts, muscle loss, tied to the labs.
- The correct diagnosis code: Your physician has to code the diagnosis, most often E29.1 (testicular hypofunction), the current ICD-10 code in the 2026 edition. Secondary (pituitary or hypothalamic) cases code differently. A missing or wrong code is one of the most common, and most fixable, reasons a claim is denied.
- Prior authorization, and sometimes step therapy: Most plans require prior authorization before covering testosterone: your doctor submits labs, the diagnosis, and clinical notes, and review can take days to weeks. Many plans also require step therapy, you try a cheaper option (usually generic injections) before they’ll approve gels or brand names.
Get all four right up front and you avoid the majority of denials. Get one wrong and even a clearly qualifying man can be turned down on a technicality.
Does insurance cover TRT by plan type? PPO, HMO, HDHP, Medicare, Medicaid & VA
The criteria above are fairly universal. What changes with your plan type is the friction, referrals, networks, and how much you pay.
| Plan type | How coverage works | Friction to expect | Typical out-of-pocket |
| PPO | Covers TRT for diagnosed hypogonadism; specialists without a referral | Prior auth; step therapy for gels/brands | Copay on generic injections, often modest |
| HMO | Covers it, but usually needs a referral to endocrinology/urology | Referral plus prior auth; tighter network | Low copay in-network; nothing out-of-network |
| HDHP + HSA | Covered, but you pay the full negotiated price until the deductible is met | Full cost early in the year; PA still applies | Deductible first, then plan rate, HSA pays pre-tax |
| Medicare | Part B covers in-office administration; Part D covers self-administered forms | Same two-test bar; formulary tiers; not all clinics accept assignment | 20% coinsurance (Part B) or a Part D copay |
| Medicaid | State-specific, some cover reliably, others don’t | Varies widely by state | Low to none where covered |
| VA | Covered for eligible veterans with documented necessity | VA provider evaluation; favors injectables | Minimal |
Two things to note. On an HDHP, TRT is technically “covered” but you’ll pay the full negotiated price until you hit your deductible, so early-year cost can look like no coverage at all. And whatever your plan, an HSA or FSA lets you pay with pre-tax dollars, which effectively discounts TRT by 20–30% depending on your tax bracket, even for care your plan won’t reimburse.
Does Medicare cover testosterone?
Yes, conditionally. Part B covers testosterone administered in a clinical setting, after the deductible, Medicare pays 80% and you pay 20%, while Part D covers at-home forms through your plan’s formulary, now backed by roughly a $2,000 annual cap on out-of-pocket drug costs. What Medicare won’t cover is TRT for age-related or idiopathic low testosterone without an underlying disorder of the testicles, pituitary, or brain.
What TRT insurance won’t cover, and how to work around it
Even with a solid diagnosis, several things routinely fall outside coverage:
- “Optimization” when your levels are normal: If your testosterone is above the threshold, insurance treats therapy as elective. This is the single most common coverage gap, and the reason many symptomatic men with “normal” labs end up paying cash.
- Brand-name gels and pellets: These often sit on a non-preferred tier or require step therapy; generic injections are the covered default. Compounded testosterone and pellets are frequently excluded as not FDA-approved.
- Ancillary medications: HCG, anastrozole, and enclomiphene are commonly denied or need separate authorizations.
- Clinic membership and telehealth fees: Concierge, membership, and platform fees aren’t billable to insurance.
The workaround for most of these is the same: generic injectable testosterone is the cheapest and most widely covered form, and an HSA/FSA covers the rest with pre-tax dollars. Where coverage isn’t possible at all, cash-pay pricing is often more predictable than fighting tier restrictions, more on that below.
Does your insurer cover TRT? Aetna, Blue Cross Blue Shield, UnitedHealthcare, Cigna & Kaiser
Major insurers converge on the same medical-necessity logic, with company-specific quirks. Treat the table as a starting point, your member-specific plan document always governs, and Blue Cross Blue Shield in particular varies because it operates as dozens of independent state affiliates.
| Insurer | Covers TRT? | Threshold | Prior auth? | Notable |
| UnitedHealthcare | Yes, for diagnosed hypogonadism | Two AM total T <300, or one low free/bioavailable | Yes | Excludes compounded pellets as not medically necessary |
| Aetna | Yes, with established necessity | Two low AM readings + symptoms | Yes | May require evaluation of reversible causes first |
| Blue Cross Blue Shield | Generally yes | ~Two sub-300 readings | Usually | Criteria vary by state affiliate, check your local plan |
| Cigna | Yes, when criteria are met | Two low AM readings | Yes | Generic injectables preferred; gels tiered higher |
| Kaiser | Yes, within its integrated system | Two low readings + symptoms | Internal review | Formulary favors generic injectable testosterone |
The pattern here is consistent with two morning labs, documented symptoms, prior authorization, generic injection first. Bring all of that, and most of these plans cover replacement.
6 common reasons why TRT gets denied by insurance
Most denials are procedural problems with the paperwork. They rarely mean the insurer decided you don’t need treatment. The six most common are:
- Your levels weren’t low enough: Above the threshold, it reads as optimization and gets declined.
- Only one test on file: Plans want two separate morning draws; one won’t clear it.
- Thin symptom documentation: Labs without a documented clinical picture look elective.
- Wrong or missing diagnosis code: No E29.1 (or the appropriate code), no easy approval.
- No prior authorization: The most avoidable denial of all, the PA simply wasn’t filed, or was filed incomplete.
- Non-preferred formulation: You were prescribed a brand-name gel where the plan requires generic injections first.
Notice that five of the six are fixable with better documentation or a resubmission. That’s exactly why appeals succeed as often as they do.
How to appeal a TRT denial (step-by-step)
A denial isn’t the end, it’s the start of a process most people never use. Fewer than 1% of denied claims are appealed, yet a large share of the ones that are, win. Here’s the process, in order:
- Internal appeal: Your first move. Submit both morning labs, a full panel (total and free testosterone, LH, FSH, CBC), documented symptoms, and a medical-necessity letter citing the Endocrine Society clinical practice guideline. Roughly 44% of internal appeals overturn the denial. You typically have 180 days from the denial letter to file.
- Peer-to-peer review: Have your physician request a direct conversation with the insurer’s medical director. This doctor-to-doctor call resolves denials more effectively than paperwork, and most men don’t know it exists.
- External independent review: If internal appeals fail, an impartial third party reviews the case. Independent reviewers overturn a meaningful share of the denials that reach them, and for prior-authorization denials specifically, success rates are high when the appeal is actually pursued. You generally have about four months to request it.
- State insurance department complaint: Filing with your state regulator signals you’re prepared to escalate, which often prompts reconsideration.
Urgent cases can be expedited, decisions within 72 hours where a delay would harm your health. Persistence and documentation win and the men who get covered are usually the ones who didn’t stop at the first no.
TRT medical necessity letter: Free appeal template
The core of any successful appeal is a letter of medical necessity from your physician. A strong one includes your diagnosis and code, both lab values with dates, a documented symptom history, the treatment rationale tied to clinical guidelines, and a clear request. Here’s a template you and your doctor can adapt:
[Date]
[Insurance Company Name] Attn: Appeals Department / Medical Director [Address from your denial letter]
Re: Appeal of Denial for Testosterone Replacement Therapy Member name: [Your full name] Member ID / Policy number: [Number] Claim / Reference number: [From denial letter] Date of denial: [Date]
To the Appeals Review Team,
I am formally appealing the denial of coverage for testosterone replacement therapy (TRT) issued on [date of denial]. This treatment is medically necessary to manage my diagnosed hypogonadism, and the supporting clinical evidence is outlined below.
Diagnosis: Hypogonadism (ICD-10 [E29.1 or applicable code]), diagnosed by [physician name, credentials] on [date].
Laboratory evidence:
- Morning total testosterone: [value] ng/dL on [date] (reference range: [range])
- Morning total testosterone: [value] ng/dL on [date] (reference range: [range])
- Additional labs: free testosterone [value], LH [value], FSH [value]
Symptoms documented in my medical record: [e.g., persistent fatigue, low libido, erectile dysfunction, depressed mood, loss of muscle mass, reduced concentration], present for [duration].
Clinical rationale: My treating physician has determined that TRT is the appropriate treatment for my condition, consistent with the Endocrine Society Clinical Practice Guideline for testosterone therapy in men with hypogonadism. [Prior treatments tried and their outcomes, if any.]
I request that you overturn this denial and approve coverage for the prescribed therapy. Enclosed are my lab results, my physician’s letter of medical necessity, and relevant clinical notes. Please confirm receipt and provide a written decision within the timeframe required by my plan.
If this appeal is upheld as a denial, I request all information necessary to pursue an external independent review.
Sincerely, [Your name] [Phone / email]
Enclosures: lab results; physician letter of medical necessity; clinical notes; copy of denial letter
TRT cost without insurance: cash-pay, HSA & FSA options
Sometimes the appeal isn’t worth it. A generic vial can cost less than the copay you’re fighting over, and if your labs read “normal,” insurance was never going to pay for optimization in the first place. In those cases, cash-pay is the cleaner path.
Out of pocket, TRT generally runs from around $150–$200/month for generic injections up to $300–$500 for gels, with pellets higher. Two things make cash-pay more manageable than it looks: generic injectable testosterone is inexpensive, and HSA/FSA dollars cover physician-prescribed TRT pre-tax, an effective 20–30% discount. For a full breakdown of what you’re actually paying for, see our guide to how much TRT costs.
Conclusion
Know your numbers, document your symptoms, and don’t stop at the denial.
If you’re not sure which side of the line you’re on, genuinely deficient and coverable, or symptomatic with “normal” labs that insurance won’t touch, the most useful next step is a proper workup. Action TRT starts with a free consultation and comprehensive labs that produce exactly the record this whole process runs on: morning testosterone values, a documented symptom picture, and a clear diagnosis.
If you qualify for covered replacement, that’s the documentation your insurer needs. And if your labs come back “normal” while you still feel like a shadow of yourself, the optimization gap insurance ignores that’s the problem we’re built to solve, with HSA/FSA dollars covering it pre-tax.
